Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
Clinical trial NCT04516746 · COMPLETED
Trial details
- NCT number
- NCT04516746
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2021-03-05
- Enrollment
- 32450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.